Skip to content

Clinical trials

Completed Phase 1 Immunoblastic Lymphadenopathy trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Immunoblastic Lymphadenopathy Phase: Phase 1 Status: Completed Clear all

83 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20015
20026
20033
20045
20052
20065
20076
20085
20093
20106
20113
20122
20131
20142
20171
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed83

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)27
National Institutes of Health Clinical Center (CC)6
Memorial Sloan Kettering Cancer Center4
Case Comprehensive Cancer Center2
M.D. Anderson Cancer Center2
NYU Langone Health2
Northwestern University2
Roswell Park Cancer Institute2
SWOG Cancer Research Network2
University of Wisconsin, Madison2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Immunoblastic Lymphadenopathy83
Lymphoma, Large-Cell, Anaplastic81
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma73
Lymphoma, Large B-Cell, Diffuse72
Lymphoma, Follicular71
Lymphoma, Mantle-Cell71
Burkitt Lymphoma70
Hodgkin Disease70
Lymphoma, B-Cell, Marginal Zone70
Leukemia, Lymphocytic, Chronic, B-Cell69

Trials

Showing 1 to 25 of 83. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.